About

Mario de Angelis is a pioneering urologic surgeon whose research focuses on advancing minimally invasive and robotic-assisted surgery for bladder and prostate cancers. His major contributions center on improving perioperative outcomes and long-term functional results after radical cystectomy, particularly through the implementation of standardized complication reporting as recommended by EAU guidelines. His work on urinary diversion trends, analyzing over 6,400 patients across 23 international centers, provides critical insights into clinical decision-making. Notably, de Angelis led Europe’s first telesurgery procedure using the Toumai® system for robot-assisted radical prostatectomy, a landmark achievement in surgical innovation. He has also addressed the practical challenges of telesurgery, proposing a new classification for intraoperative complications when network failures occur. His research on multimodal treatment for oligometastatic prostate cancer and long-term functional outcomes after orthotopic neobladder reconstruction demonstrates a commitment to both oncological efficacy and quality of life. With papers accumulating citations from 2023-2025, his work is rapidly shaping contemporary urologic practice, particularly in high-volume referral centers across Europe.

Research Focus

Key Achievements

4
H-Index
7
Papers
42
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center
19 citations · 2024
📈 Most Prolific Year: 2025 (4 Papers)
🤝 Key Collaborators: 97
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, Onze Lieve Vrouwziekenhuis Hospital, IRCCS Ospedale San Raffaele

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago